OBJECTIVE: To evaluate the relationship between plasma leptin and the tumor necrosis factor-a (TNFa), TNF receptor p60 (TNF-R1) and TNF receptor p80 (TNF-R2) concentrations in obese subjects. DESIGN: Case-control study. SETTING: Outpatient's Service for Prevention and Treatment of Obesity at the University Hospital. MEASUREMENTS: Body mass index (BMI), waist circumference, hip circumference, waist-to-hip ratio (WHR), fasting plasma glucose, fasting plasma insulin, homeostasis model assessment of insulin resistance (HOMA IR), plasma leptin, TNFa a, TNF-R1 and TNF-R2 concentrations were evaluated in obese subjects (n 42) and in age-and gendermatched, lean healthy controls (n 16). RESULTS: In obese subjects, fasting plasma glucose and insulin, HOMA IR, plasma leptin, TNFa a, TNF-R1 and TNF-R2 concentrations were signi®cantly higher than in controls. Furthermore, females showed higher leptin, TNF-R1 and TNF-R2 plasma concentrations compared to males, in both control and obese subjects. In control subjects, plasma leptin concentrations showed a direct correlation with BMI (r 0.74, P`0.001), hip circumference (r 0.94, P`0.001), TNF-R1 (r 0.79, P`0.001) and TNF-R2 (r 0.64, P`0.01), and a negative correlation with WHR (r À À0.58, P`0.05). In obese subjects, we found a direct correlation between plasma leptin concentrations and BMI (r 0.67, P`0.001), hip circumference (r 0.66, P`0.001), fasting glucose (r 0.37, P`0.05), fasting insulin (r 0.31, P`0.05), HOMA IR (r 0.38, P`0.05), TNF-R1 (r 0.71, P`0.001) and TNR-R2 (r 0.66, P`0.001), while a negative correlation was found between circulating leptin and WHR (r À À0.44, P`0.01). In multivariate analysis, plasma leptin concentrations were signi®cantly associated with BMI (P 0.015) and gender (P 0.047) in the control group, while in obese subjects, plasma leptin showed a signi®cant association with BMI (P 0.019) and TNF-R1 (P 0.012). CONCLUSIONS: Our results are consistent with the hypothesis that the TNFa a system could be involved in the regulation of plasma leptin concentrations in obese subjects.
Introduction
The recent cloning of the mouse and human obese (ob) genes, 1 has been a relevant breakthrough for the understanding of the pathophysiology of obesity. Leptin, the product of the ob gene, is an adipose-tissue secreted protein that signals the size of energy stores to the central nervous system, 2±6 thus affecting hypothalamic centers involved in food-intake and energy balance regulation. 5, 6 When administered to obaob mice, leptin increases energy expenditure, 6 decreases body weight, and normalizes hyperglycaemia, insulin resistance and hyperinsulinaemia.
6 ±9 On the other hand, the signalling pathways that regulate leptin production and secretion are still largely unknown. It has recently been reported that tumor necrosis factor-a (TNFa) could be involved in the pathogenesis of insulin resistance.
10 ±12 This cytokine is produced in excess by adipocytes of obese individuals, and this results in a decrease in insulin-receptor kinase activity in muscle and fat, thus contributing to the onset of obesity-related insulin resistance. 13 Furthermore, the activation of the TNFa system seems to be associated with increased energy expenditure and weight loss in humans.
14 ±17 These ®ndings seem to support the hypothesis that the TNFa system may regulate, or even act through, the leptin system, to increase energy expenditure and decrease body weight in in¯amma-tory disease and cancer. 18 Moreover, TNFa seems to be capable of regulating leptin secretion in mice at the post-translational level, probably by inducing the release of a preformed adipocyte pool of leptin. 19 It has also been recently demonstrated that TNFa administration in patients with solid tumors, increases circulating leptin concentrations. 20 In the light of these ®ndings, it has been hypothesized that TNFa may be a part of the adipostatic mechanism linking plasma leptin concentrations to adipocyte triglyceride stores, and may potentiate adipocyte insulin resistance effects due to an autocrine or paracrine effect of leptin on the same insulin signalling pathways. 19 An association between TNFa system activity, measured by serum TNFa receptor p60 (TNF-R1) immunoassay and serum leptin, has recently been found in healthy subjects and in patients with non-insulin dependent diabetes mellitus (NIDDM), 21 and increased TNFa receptor p80 (TNF-R2) plasma concentrations have been observed in obese women. 22 Therefore the aim of this case-control study, was to investigate the relationship between leptin and TNFa system activity, measured by plasma TNFa, TNF-R1 and TNF-R2 immunoassay, in obese subjects.
Methods

Patients and controls
Our series consisted of 42 obese subjects attending our Outpatient's Service for Prevention and Treatment of Obesity who gave their informed consent to participate. The subjects were de®ned as obese, according to Garrow's criteria (body mass index, BMI b 30 kgam 2 ). 23 Height was measured without shoes to the nearest 0.5 cm; body weight was measured without clothes to the nearest 0.1 kg; BMI was measured as weightaheight 2 (kgam 2 ); waist circumference was measured midway between the lower rib margin and the iliac crest, hip circumference was determined as the widest circumference measured over the greater trochanters. The waist-to-hip ratio (WHR) was then calculated. 24 The control group consisted of 16 ageand gender-matched lean subjects (BMI`25 kgam 2 ). All the enrolled subjects had not taken drugs for at least one month before the study, nor were they on special diets. In all subjects, a venous blood sample with EDTA was taken in the morning, between 08.00 h and 09.00 h, after a 12 h overnight fast. Plasma samples obtained by centrifugation were stored a 7 70 C until the assays were performed.
Laboratory methods
In all the samples, the following parameters were assayed: fasting plasma glucose ( 
Results
In the group of obese patients studied, leptin, TNFa, TNF-R1 and TNF-R2 plasma concentrations were signi®cantly higher than in controls. Obese subjects also had increased fasting glucose, insulin and HOMA IR with respect to controls (Table 1) . Furthermore, when we divided the subjects studied according to their gender, female subjects showed higher leptin, TNF-R1 and TNF-R2 plasma concentrations with respect to males, in both control and obese groups. However, such a sexual dimorphism was not detectable for plasma TNFa concentrations ( Table 2) . Leptin and TNFa system in the obese F Corica et al
In control subjects, bivariate correlation analysis showed that plasma leptin concentrations were directly correlated to BMI, hip circumference, TNF-R1 and TNF-R2 plasma concentrations, while a negative correlation was found between circulating leptin and WHR (Table 3) . Moreover, a direct correlation was found between TNF-R1 and BMI (r 0.54, P`0.01), and hip circumference was positively correlated with TNF-R1 (r 0.77, P`0.001) and TNF-R2 (r 0.65, P`0.01). BMI correlation to TNFa (r 0.45, P 0.08) and TNF-R2 (r 0.43, P 0.09) did not reach statistical signi®cance.
In obese subjects, circulating leptin concentrations showed a direct correlation with BMI, hip circumference, fasting glucose, fasting insulin, HOMA IR, TNF-R1 and TNF-R2 plasma concentrations, while a negative correlation was detected between plasma leptin concentrations and WHR (Table 3) . Obese subjects also showed a positive correlation between BMI and TNFa (r 0.44, P`0.01), TNF-R1 (r 0.58, P`0.01) and TNF-R2 (r 0.64, P`0.001) plasma concentrations, HOMA IR (r 0.44, P`0.01) and fasting insulin (r 0.45, P`0.01). Furthermore, hip circumference showed a direct correlation with TNF-R1 (r 0.46, P`0.01) and TNF-R2 (r 0.56, P`0.001). A direct correlation was found between fasting insulin and TNFa r 0.33, P`0.05), TNF-R1 (r 0.43, P`0.01) and TNF-R2 (r 0.34, P`0.05) plasma concentrations, and HOMA IR was correlated to TNF-R1 (r 0.47, P`0.01) and TNF-R2 (r 0.41, P`0.001).
Finally, we performed a multiple linear regression analysis in two separate models for control and obese subjects, using plasma leptin as a dependent variable. Plasma leptin concentrations were signi®cantly associated with BMI and gender in the control group, while in obese subjects, plasma leptin showed a signi®cant association with BMI and plasma TNF-R1 (Table 4 ). The independent association between leptin and TNF-R1 plasma concentrations in obese subjects was also con®rmed after adjusting for waist and hip circumferences instead of WHR, and for fasting plasma glucose and insulin instead of HOMA IR (P 0.01).
Discussion
The mechanisms involved in the regulation of feeding behaviour and energy expenditure, are still largely unknown and, in this ®eld, recent studies seem to indicate the existence of a functional overlapping between leptin and TNFa. First, both leptin and TNFa are produced by adipose tissue proportionally to the amount of fat stores 11Y12Y27À29 and are capable of affecting feeding behaviour and energy Leptin and TNFa system in the obese F Corica et al expenditure. 6, 30, 31 Second, leptin and TNFa production seem to be enhanced through the same pathways 18, 32 and their mRNA expression increases during weight gain and falls during weight loss. 12, 28 Third and ®nally, lower plasma leptin levels have been found in TNFa-de®cient mice with respect to wild-type animals, 19 and TNFa administration has been shown to be able to increase circulating leptin concentrations in patients with solid tumors. 20 The assessment of TNFa system activity on the basis of plasma TNF receptors (TNF-Rs) concentrations, seems to be more reliable and of greater interest than the plasma TNFa concentration itself. In fact, these proteins are easily detectable in plasma and seem to act as a buffer system, prolonging the biological effects of TNFa. 33 Furthermore, they seem to re¯ect more accurately the degree of TNFa system activation than circulating TNFa concentrations, 34 and remain elevated for longer periods of time. 33, 34 In agreement with the ®ndings reported by Mantzoros et al 21 in healthy and diabetic subjects, our study demonstrates the existence of a close relationship between plasma leptin and TNF-R1 concentrations in obese subjects. However, unlike Mantzoros et al 21 we did not ®nd a signi®cant association between leptin and TNF-R1 plasma concentrations in lean controls after adjusting for BMI in multivariate analysis. This apparent discrepancy is probably due to the greater number of lean subjects enrolled in the former study.
Our results also differ from a previous report by Hotamisligil et al 22 indicating that TNF-R1 plasma concentrations do not differ between lean and obese female subjects, while the TNF-R2 plasma concentration is signi®cantly elevated in obese women. The only relevant difference is in the gender of the subjects studied, as half of the control subjects and one third of the obese subjects were male in the present paper, while only female subjects were considered in the previous study. In agreement with Hotamisligil et al, 22 our results indicate that TNF-R2 plasma concentrations are signi®cantly higher in obese patients than in controls. Further studies will be necessary to better clarify the exact role of TNF-Rs in obesity.
The positive association between circulating leptin and TNF-R1 plasma concentrations observed by us in obese subjects after adjustment for age, gender anthropometric variables and insulin resistance parameters, seems to con®rm that the leptin and TNFa systems are strictly linked in humans, 21 similar to rodents. 18, 32 As regards the anthropometric variables studied, in bivariate analysis, TNF-R1, similarly to leptin, was directly correlated with BMI and hip circumference in both control and obese subjects. Moreover, TNFa and TNF-R2 were directly correlated to BMI and hip circumference in obese subjects. These results seem to con®rm the hypothesis of an overlapping of the mechanisms that regulate leptin and TNFa systems. However, in multivariate analysis, no statistically signi®cant association was found between WHR and plasma leptin concentration. Although recently reported ®ndings demonstrate the existence of a direct relationship between circulating leptin and hip circumference, 35, 36 other authors found that WHR does not seem to signi®cantly affect leptin and TNF-R1 plasma concentrations. 21 On the other hand, it should be borne in mind that plasma leptin concentrations are related to total fat mass, and do not seem to be affected by the distribution of fat between peripheral and abdominal stores. 37 Our ®nding, that both healthy and obese women had higher leptin, TNF-R1 and TNF-R2 plasma concentrations than men, is of particular interest. In fact, it is known that women have higher plasma leptin levels than men with a similar BMI. 38, 39 The sexual dimorphism of TNF-R1 plasma concentrations observed by us in both control and obese subjects, seems to be in agreement with previously reported ®ndings, 21 and TNF-R2 also showed a similar sexual dimorphism in our study. These observations could at least partially explain the concurrent sexual dimorphism of circulating leptin, as it has been demonstrated that TNFa can act as a secretagogue stimulus on adipocyte. 19 On the other hand, the role of the leptin-TNFa pathway in obesity seems to be more complex, Leptin and TNFa system in the obese F Corica et al probably being involved in the pathophysiology of the obesity-related metabolic derangement. In fact, the obesity-related enhancement in leptin production has been positively correlated to hyperinsulinaemia and increased insulin resistance, 29, 30 and insulin-resistance seems to be associated to increased leptin concentrations, independent of body fat mass. 40 Furthermore, TNFa expression is closely related to insulin concentrations 10, 12 and the glucose disposal rate during the euglycaemic clamp, 41 similar to leptin, 42 and the existence of a TNFa gene polymorphism that may exacerbate the alterations in plasma leptin concentrations observed in insulin resistant subjects 43 has recently been demonstrated. Additionally, the fact that the improved insulin sensitivity occurring with weight loss, is associated with a reduced TNFa mRNA expression in adipose tissue, is particularly intriguing. 12 In fact, TNFa could be involved in the pathophysiology of the insulin resistance state in obesity, 44 probably affecting the insulin-stimulated insulin receptor (IR) phosphorylation mechanisms and the subsequent tyrosine phosphorylation of the insulin receptor substrate-1 (IRS-1). 45Y46 In bivariate analysis, our data con®rm the existence of a direct relationship between plasma leptin and insulin concentrations, 42 and demonstrate that plasma leptin is also directly related to HOMAIR in obese subjects. Moreover, TNFa, TNF-R1 and TNF-R2 plasma concentrations were positively correlated to plasma insulin in obese subjects, while HOMAIR showed a direct correlation with plasma TNF-R1 and TNF-R2 in the obese. Our results con®rm previous ®ndings of a link between insulin resistance and plasma TNF-R1 concentrations, 47 and are consistent with recent reports suggesting that TNF-R2 could play a role in human obesity and in obesity-related insulin resistance. 22, 48 Furthermore, Hotamisligil et al 13 found a marked increase in insulin-stimulated autophosphorylation of the IR, as well as phosphorylation of IRS-1 in muscle and fat tissues from Zucker fatty rats, after neutralization of TNFa with a soluble TNF receptor (TNFR)-IgG fusion protein. Thus, our ®nding that in multivariate analysis, leptin is signi®cantly and independently predicted by TNF-R1 in obese subjects, is consistent with TNFa system hyperactivity representing a common pathway in the pathophysiology of insulin-resistance and hyperleptinaemia in the obese. Finally, it cannot be ruled out that the obesityrelated TNFa system hyperactivity could act as a mechanism to limit further fat cell enlargement through the induction of adipose tissue insulin resistance 49 and increased leptin expression in obese subjects could have a similar role.
Conclusions
Our study demonstrates the existence of an independent positive association between leptin and TNF-R1 plasma concentrations in obese subjects. These data are consistent with the hypothesis that TNFa could be involved in regulating plasma leptin concentrations in obese subjects. Further studies on the leptin-TNFa system are needed to better clarify the mechanisms involved in the obesity-related metabolic derangement, the mechanisms regulating body weight and energy expenditure in other diseases (such as in¯am-matory diseases and neoplasias), and the possible role of the leptin-TNFa pathway in modulating immune and neuroendocrine systems activity.
